Codexis Reports Third Quarter 2026 Financial Results and Provides Business UpdateGlobeNewsWire • Thursday
Codexis Advances ECO Synthesis Toward Adoption Readiness with Quality at Scale and Expanded siRNA Manufacturing CapabilitiesGlobeNewsWire • Monday
Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNAGlobeNewsWire • 09/28/26
Codexis (CDXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 ReleaseZacks Investment Research • 04/30/26